InvestorsHub Logo
Followers 5
Posts 784
Boards Moderated 0
Alias Born 07/19/2006

Re: None

Thursday, 04/11/2019 12:00:58 PM

Thursday, April 11, 2019 12:00:58 PM

Post# of 5634
Ocugen OCU310 Phase III study is likely complete and data being prepared for the public. The clinical trials site has Feb 28, 2019 as expected end date.
https://clinicaltrials.gov/ct2/show/NCT03785340?term=Ocugen&cond=Dry+Eye&rank=2

Now, they probably know the outcome and are waiting to release the news when the merger completes adding tremendous value. Would they be going public if the Phase III was a failure? I think not.

OCU300 Phase III data due in Jan 2020. So those saying the product is years away are not informed or posting falsehood
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent OCGN News